Company registration number SC106549 (Scotland)
GATE HEALTHCARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
GATE HEALTHCARE LIMITED
CONTENTS
Page
Company information
1
Strategic report
2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 16
Detailed profit and loss account
17
GATE HEALTHCARE LIMITED
COMPANY INFORMATION
- 1 -
Directors
C J Moule
N Seymour
S Clarke-Kuehn
L Blackwood
Secretary
N Seymour
Company number
SC106549
Registered office
Sanctuary House
7 Freeland Drive
Glasgow
Scotland
G53 6PG
Auditor
Consilium Audit Limited
169 West George Street
Glasgow
Scotland
G2 2LB
GATE HEALTHCARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -

The directors present the strategic report for the year ended 31 March 2024.

Review of business

Gate Healthcare Limited operates three care homes owned by its immediate parent Lorimer Care Homes Limited. The company’s aim is to provide a care service for older persons, placing emphasis on promoting health and independence.

 

The Company has seen increased turnover as occupancy continues to recover post pandemic, however operating costs have been negatively impacted by rising energy costs. 

Outlook

The company’s outlook is very positive with all homes performing well and ongoing improvement projects underway to further enhance our services.

Key performance indicators

The operating result has increased to an operating profit of £145,813 (2022: loss of £68,005).

At the period end the company had shareholders funds of £5,283,928 (2023: £5,283,928). The directors therefore believe the company’s position to be satisfactory.

Principal risks and uncertainties

The principle risks facing the business remain recruitment and retention of quality staff and the ability to maintain occupancy in challenging environments.  The directors believe that the quality of service provided and the strong reputation of the homes minimises the impact of these risks.

Financial risk management objectives and policies

The company finances its operations through its retained profits. Management’s objective is to retain sufficient liquid funds to enable it to meet its day to day obligations as they fall due.

On behalf of the board

L Blackwood
Director
24 September 2024
GATE HEALTHCARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2024
- 3 -

The directors present their annual report and financial statements for the year ended 31 March 2024.

Principal activities

The principal activity of the company continued to be that of the operation of residential nursing care facilities.

Results and dividends

The results for the year are set out on page 8.

No ordinary dividends were paid during the period. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

L Blackwood
S Clarke-Kuehn
C Moule
N Seymour
Auditor

The auditor, Consilium Audit Limited, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

GATE HEALTHCARE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 4 -
On behalf of the board
L Blackwood
Director
24 September 2024
GATE HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF GATE HEALTHCARE LIMITED
- 5 -
Opinion

We have audited the financial statements of Gate Healthcare Limited (the 'company') for the year ended 31 March 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

GATE HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF GATE HEALTHCARE LIMITED
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

 

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

 

 

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence.

 

Material misstatements that arise due to fraud can be harder to detect than those arisen from error as they may involve deliberate concealment or collusion.

GATE HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF GATE HEALTHCARE LIMITED
- 7 -

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Brian Thomson BA(Hons) CA
Senior Statutory Auditor
For and on behalf of Consilium Audit Limited
Statutory Auditor
169 West George Street
Glasgow
Scotland
G2 2LB
24 September 2024
GATE HEALTHCARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2024
- 8 -
2024
2023
Notes
£
£
Turnover
5,693,800
5,100,822
Cost of sales
(4,249,104)
(4,021,330)
Gross profit
1,444,696
1,079,492
Administrative expenses
(1,298,883)
(1,158,441)
Other operating income
-
0
10,944
Profit/(loss) before taxation
145,813
(68,005)
Tax on profit/(loss)
4
-
0
(31,624)
Profit/(loss) for the financial year
145,813
(99,629)

The statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

The notes on pages 11 to 16 form part of these financial statements.

GATE HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 9 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
6
5,683,348
5,828,413
Cash at bank and in hand
989,444
200,093
6,672,792
6,028,506
Creditors: amounts falling due within one year
7
(1,388,864)
(744,578)
Net current assets
5,283,928
5,283,928
Capital and reserves
Called up share capital
9
50
50
Capital redemption reserve
55
55
Profit and loss reserves
5,283,823
5,283,823
Total equity
5,283,928
5,283,928

The notes on pages 11 to 16 form part of these financial statements.

The financial statements were approved by the board of directors and authorised for issue on 24 September 2024 and are signed on its behalf by:
L Blackwood
Director
Company Registration No. SC106549
GATE HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2024
- 10 -
Share capital
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2022
50
55
5,383,452
5,383,557
Year ended 31 March 2023:
Loss and total comprehensive income for the year
-
-
(99,629)
(99,629)
Balance at 31 March 2023
50
55
5,283,823
5,283,928
Year ended 31 March 2024:
Profit and total comprehensive income for the year
-
-
145,813
145,813
Distributions to parent charity under gift aid
5
-
-
(145,813)
(145,813)
Balance at 31 March 2024
50
55
5,283,823
5,283,928

The notes on pages 11 to 16 form part of these financial statements.

GATE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 11 -
1
Accounting policies
Company information

Gate Healthcare Limited is a private company limited by shares incorporated in Scotland. The registered office is Sanctuary House, 7 Freeland Drive, Glasgow, Scotland, G53 6PG. The company's registration number is SC106549.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

The turnover shown in the Statement of Comprehensive Income represents the value of all services delivered at a selling price exclusive of Value Added Tax. Sales are recognised at the point at which the Company has fulfilled its contractual obligations.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

GATE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 12 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in the profit and loss account, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

GATE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 13 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.7
Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.9
Leases

Rentals applicable to operating leases, where substantially all of the benefits and risks of ownership remain with the lessor, are charged against profits on a straight line basis over the period of the lease.

1.10
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Operating profit/(loss)
2024
2023
Operating profit/(loss) for the year is stated after charging/(crediting):
£
£
Government grants
-
(10,944)
Operating lease charges
465,000
465,000
The audit fee for the year was borne by another group entity.
GATE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 14 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Administrative staff
4
4
Care staff
173
172
Total
177
176

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
3,565,396
3,323,457
Social security costs
266,184
243,593
Pension costs
100,855
77,754
3,932,435
3,644,804
4
Taxation
2024
2023
£
£
Current tax
Adjustments in respect of prior periods
-
0
31,624

There is an increase in the UK corporate tax rate from 19% to 25% (effective from 1 April 2023) which was enacted on 11 March 2021. The UK corporate tax has been charged at 25% (2023 - 19%). The deferred tax as at the balance sheet date has been calculated at 25%.

The actual charge for the year can be reconciled to the expected charge/(credit) for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit/(loss) before taxation
145,813
(68,005)
Expected tax charge/(credit) based on the standard rate of corporation tax in the UK of 25.00% (2023: 19.00%)
36,453
(12,921)
Unutilised tax losses carried forward
-
0
12,921
Under/(over) provided in prior years
-
0
31,624
Tax relief in respect of gift aid
(36,453)
-
0
Taxation charge for the year
-
31,624
GATE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 15 -
5
Dividends and distributions
2024
2023
£
£
Distributions to parent charity under gift aid
Amounts paid
145,813
-
0
6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
239,417
242,705
Amounts owed by group undertakings
5,372,152
5,535,458
Prepayments and accrued income
71,779
50,250
5,683,348
5,828,413
Amounts owed by group undertakings are interest free and repayable on demand.
7
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
134,025
120,356
Amounts owed to group undertakings
310,311
38,985
Other creditors
7,907
6,942
Accruals and deferred income
936,621
578,295
1,388,864
744,578
Amounts owed to group undertakings are interest free and repayable on demand.
8
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
100,855
77,754

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

9
Share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
50 Ordinary shares of £1
50
50
GATE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 16 -
10
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2024
2023
£
£
Within one year
465,506
471,068
Between two and five years
426,250
891,756
891,756
1,362,824
11
Related party transactions

The company has taken advantage of the exemption available under Financial Reporting Standard 102 not to disclose related party transactions with the ultimate parent company or with any wholly owned subsidiaries within the group.

 

No further transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and the Republic of Ireland".

12
Ultimate parent undertaking and controlling party

The immediate parent undertaking is Lorimer Care Homes Limited.

 

Sanctuary Housing Association is regarded by the directors as being the company's ultimate parent undertaking and controlling party.

 

The company is included by full consolidation in the consolidated financial statements of its ultimate parent, Sanctuary Housing Association registered at Sanctuary House, Chamber Court, Castle Street, Worcester, WR1 3ZQ, England. Copies of the consolidated financial statements are available at this address.

2024-03-312023-04-01falseCCH SoftwareCCH Accounts Production 2024.200C J MouleS Clarke-KuehnL BlackwoodL BlackwoodN SeymourfalsetrueSC1065492023-04-012024-03-31SC106549bus:Director12023-04-012024-03-31SC106549bus:CompanySecretaryDirector12023-04-012024-03-31SC106549bus:Director22023-04-012024-03-31SC106549bus:Director32023-04-012024-03-31SC106549bus:CompanySecretary12023-04-012024-03-31SC106549bus:Director42023-04-012024-03-31SC106549bus:RegisteredOffice2023-04-012024-03-31SC1065492024-03-31SC1065492022-04-012023-03-31SC106549core:RetainedEarningsAccumulatedLosses2022-04-012023-03-31SC106549core:RetainedEarningsAccumulatedLosses2023-04-012024-03-31SC1065492023-03-31SC106549core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-31SC106549core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-31SC106549core:CurrentFinancialInstruments2024-03-31SC106549core:CurrentFinancialInstruments2023-03-31SC106549core:ShareCapital2024-03-31SC106549core:ShareCapital2023-03-31SC106549core:CapitalRedemptionReserve2024-03-31SC106549core:CapitalRedemptionReserve2023-03-31SC106549core:RetainedEarningsAccumulatedLosses2024-03-31SC106549core:RetainedEarningsAccumulatedLosses2023-03-31SC106549core:ShareCapital2022-03-31SC106549core:CapitalRedemptionReserve2022-03-31SC106549core:RetainedEarningsAccumulatedLosses2022-03-31SC106549core:UKTax2023-04-012024-03-31SC106549core:UKTax2022-04-012023-03-31SC10654912023-04-012024-03-31SC10654912022-04-012023-03-31SC10654922023-04-012024-03-31SC10654922022-04-012023-03-31SC106549core:WithinOneYear2024-03-31SC106549core:WithinOneYear2023-03-31SC106549core:BetweenTwoFiveYears2024-03-31SC106549core:BetweenTwoFiveYears2023-03-31SC106549bus:PrivateLimitedCompanyLtd2023-04-012024-03-31SC106549bus:FRS1022023-04-012024-03-31SC106549bus:Audited2023-04-012024-03-31SC106549bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP